IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 174 filers reported holding IMPAX LABORATORIES INC in Q2 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $13,035,000 | +19.0% | 670,206 | +1.9% | 0.00% | 0.0% |
| Q4 2017 | $10,956,000 | -18.9% | 658,031 | -1.2% | 0.00% | -20.0% |
| Q3 2017 | $13,514,000 | +29.3% | 665,721 | +2.6% | 0.01% | +25.0% |
| Q2 2017 | $10,451,000 | +21.0% | 649,144 | -4.9% | 0.00% | 0.0% |
| Q1 2017 | $8,634,000 | -5.2% | 682,560 | -0.8% | 0.00% | 0.0% |
| Q4 2016 | $9,112,000 | -35.1% | 687,801 | +16.1% | 0.00% | -42.9% |
| Q3 2016 | $14,039,000 | -16.4% | 592,410 | +1.6% | 0.01% | -22.2% |
| Q2 2016 | $16,796,000 | +4.9% | 582,823 | +16.5% | 0.01% | +12.5% |
| Q1 2016 | $16,013,000 | -20.1% | 500,150 | +6.7% | 0.01% | -27.3% |
| Q4 2015 | $20,044,000 | +26.9% | 468,763 | +4.5% | 0.01% | +10.0% |
| Q3 2015 | $15,790,000 | -23.7% | 448,478 | -0.5% | 0.01% | -16.7% |
| Q2 2015 | $20,694,000 | -1.3% | 450,671 | +0.8% | 0.01% | 0.0% |
| Q1 2015 | $20,959,000 | +58.3% | 447,204 | +7.0% | 0.01% | +50.0% |
| Q4 2014 | $13,236,000 | +42.8% | 417,807 | +6.9% | 0.01% | +33.3% |
| Q3 2014 | $9,268,000 | -20.7% | 390,925 | +0.4% | 0.01% | -25.0% |
| Q2 2014 | $11,680,000 | +15.0% | 389,480 | +1.3% | 0.01% | +14.3% |
| Q1 2014 | $10,158,000 | +17.0% | 384,498 | +11.4% | 0.01% | +16.7% |
| Q4 2013 | $8,680,000 | +37.1% | 345,277 | +11.9% | 0.01% | +20.0% |
| Q3 2013 | $6,330,000 | +18.2% | 308,607 | +15.0% | 0.01% | 0.0% |
| Q2 2013 | $5,355,000 | – | 268,402 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |